The effect of Achillea Cretica herbal medicine on pain and size of endometrial lesions in patients.

Comparison of the effect of Achillea Cretica herbal treatment with Dinogest on the pain and size of endometriosis lesions in patients referred to Arash Hospital.

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220408054455N1

Enrollment

Registered

2022-07-27

Start date

2022-07-06

Completion date

Unknown

Last updated

2022-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis. Endometriosis

Interventions

Intervention 1: Intervention group: Women aged 18 to 45 years with pain associated with endometriosis, who receive Achillea cretica syrup from Noush Daroo Toosan Salamat Company in addition to one din

Eligibility

Sex/Gender

Female

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Women 18 to 45 years old with pain associated with endometriosis

Exclusion criteria

Exclusion criteria: Pregnancy Breastfeeding The need for endometriosis surgery treatment Amenorrhea within 3 months prior to enrollment Previous use of hormonal agents (e.g., gonadotropin agonists less than 6 months ago, progesterone or danazol less than 3 months ago, or oral contraceptives 1 month before screening) Abnormal findings in gynecological examination Risk factors for decreased bone density (e.g., family history of osteoporosis or use of anticonvulsants or corticosteroids)

Design outcomes

Primary

Measure	Time frame
Degree of dysmenorrhea using visual pain ruler. Timepoint: At the beginning of the study and three months after starting treatment. Method of measurement: Using visual pain ruler.;Degree of dyspareunia using visual pain ruler. Timepoint: At the beginning of the study and three months after starting treatment. Method of measurement: Using pain ruler.;Degree of pelvic pain using pain ruler. Timepoint: At the beginning of the study and three months after starting treatment. Method of measurement: Using pain ruler.;Size change of Endometriosis lesions by Sonography or Laparascopy. Timepoint: At the beginning of the study and three months after starting treatment. Method of measurement: By performing ultrasound or diagnostic laparoscopy.;Number Change of endometriosis lesions by performing ultrasound. Timepoint: At the beginning of the study and three months after starting treatment. Method of measurement: By performing ultrasound or diagnostic laparoscopy.	—

Measure

Time frame

Degree of dysmenorrhea using visual pain ruler. Timepoint: At the beginning of the study and three months after starting treatment. Method of measurement: Using visual pain ruler.;Degree of dyspareunia using visual pain ruler. Timepoint: At the beginning of the study and three months after starting treatment. Method of measurement: Using pain ruler.;Degree of pelvic pain using pain ruler. Timepoint: At the beginning of the study and three months after starting treatment. Method of measurement: Using pain ruler.;Size change of Endometriosis lesions by Sonography or Laparascopy. Timepoint: At the beginning of the study and three months after starting treatment. Method of measurement: By performing ultrasound or diagnostic laparoscopy.;Number Change of endometriosis lesions by performing ultrasound. Timepoint: At the beginning of the study and three months after starting treatment. Method of measurement: By performing ultrasound or diagnostic laparoscopy.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSoheila Sadat Moosavifar

Tehran University of Medical Sciences

soheilamoosavifar@gmail.com+98 912 633 5414

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026